HSDT Solana Co.

Price (delayed)

$1.39

Market cap

$81.16M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$25.63

Enterprise value

$76.76M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 15

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation ...

Highlights
Solana's EPS has surged by 99% YoY
The gross profit has soared by 64% from the previous quarter
The equity has declined by 34% since the previous quarter
The company's quick ratio fell by 3.7% QoQ

Key stats

What are the main financial stats of HSDT

HSDT stock price

How has the Solana stock price performed over time
Intraday
-6.08%
1 week
-31.86%
1 month
-35.65%
1 year
-99.15%
YTD
-51.9%
QTD
-19.65%

Financial performance

How have Solana's revenue and profit performed over time
Revenue
$9.59M
Gross profit
$9.03M
Operating income
-$339.45M
Net income
-$136.85M
Gross margin
94.2%
Net margin
-1,427.1%
The net margin has dropped by 110% since the previous quarter but it has surged by 53% year-on-year
The gross profit has soared by 64% from the previous quarter
The company's revenue has surged by 59% QoQ
Solana's operating income has decreased by 39% QoQ

Price vs fundamentals

How does HSDT's price correlate with its fundamentals

Growth

What is Solana's growth rate over time

Valuation

What is Solana stock price valuation
P/E
N/A
P/B
0.39
P/S
11.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.01
Solana's EPS has surged by 99% YoY
HSDT's P/B is 76% lower than its 5-year quarterly average of 1.7
The equity has declined by 34% since the previous quarter
HSDT's price to sales (P/S) is 76% lower than its last 4 quarters average of 49.5 and 50% lower than its 5-year quarterly average of 23.8
The company's revenue has surged by 59% QoQ

Efficiency

How efficient is Solana business performance
The ROA has shrunk by 168% QoQ but it has soared by 77% YoY
Solana's ROIC has plunged by 160% from the previous quarter but it has soared by 98% YoY
Solana's return on sales has shrunk by 112% QoQ but it has surged by 53% YoY
HSDT's return on equity has surged by 63% year-on-year but it is down by 48% since the previous quarter

Dividends

What is HSDT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HSDT.

Financial health

How did Solana financials performed over time
The total assets has declined by 34% since the previous quarter
The company's total liabilities rose by 28% YoY but it fell by 7% QoQ
The debt is 100% smaller than the equity
The equity has declined by 34% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.